- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06507670
Point of Care Ultrasound for the Detection of Esophageal Food Bolus
This will be a prospective, observational, case-control study of adult patients presenting to the WellSpan York Hospital Emergency Department (YHED) with signs and symptoms of esophageal food or foreign body impaction. Point of care ultrasound (POCUS) will then be performed by a trained emergency physician to collect ultrasound data, including the presence or absence of direct visualization food bolus/foreign body, as well as secondary markers of dilatation, such as maximal esophageal area. Investigators will also enroll an age/sex-matched control group of asymptomatic individuals to establish baseline esophageal measurements.
Patients will otherwise receive medical treatment per standard of care. Subsequent interventions will also be documented, including glucagon, carbonated beverages, and esophagogastroduodenoscopy (EGD). If patients remain in the ED and improve without need for EGD they will undergo repeat ultrasound. Chart review at 1 month will be performed to establish results of EGD including improvement, recurrence, or presence of pathologic abnormalities. The investigators aim to establish normal and abnormal parameters to aid in the diagnosis of esophageal food impactions to predict need for definitive EGD management.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Brent Becker, MD
- Phone Number: 717-851-4819
- Email: bbecker2@wellspan.org
Study Contact Backup
- Name: Kristen Oliff
- Phone Number: 717-851-5075
- Email: koliff@wellspan.org
Study Locations
-
-
Pennsylvania
-
York, Pennsylvania, United States, 17403
- Recruiting
- Wellspan Health York Hospital
-
Contact:
- Brent Becker, MD
- Phone Number: 717-851-4819
- Email: bbecker2@wellspan.org
-
Contact:
- Kristen Oliff
- Phone Number: 717-851-5075
- Email: koliff@wellspan.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Eligibility (CASES)
Inclusion criteria:
- Age ≥18 years
- Signs and symptoms of esophageal food bolus or foreign body
Exclusion criteria:
- Prior esophageal surgery
- History of head/neck cancer
- Incarcerated individuals
- Individuals unable to provide consent
- Clinical instability or airway compromise
Eligibility (CONTROLS)
Inclusion criteria:
- Age ≥18 years
- NO signs or symptoms of esophageal food bolus or foreign body
- Age/Sex match to previously enrolled case subject
Exclusion criteria:
- Prior esophageal surgery/dilation/pathology
- History of head/neck cancer
- Incarcerated individuals
- Individuals unable to provide consent
- Clinical instability or airway compromise
- Presentation involving any of the following symptoms:
- Nausea/vomiting
- Diarrhea
- Abdominal pain
- Chest pain
- Shortness of breath
- Dysphagia/odynophagia
- Cough
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Esophageal foreign body/impaction (suspected)
|
Point of care medical ultrasound machines will be used to sonographically visualize the esophagus and following sonographic data will be collected:
|
|
Control (No symptoms of esophageal foreign body/impaction)
|
Point of care medical ultrasound machines will be used to sonographically visualize the esophagus and following sonographic data will be collected:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Presence or absence of esophageal foreign body/food impaction
Time Frame: Within 48 hours of index visit (Emergency department arrival to emergency department or hospital discharge)
|
Presence of absence of esophageal foreign body/food impaction on esophagogastroduodenoscopy
|
Within 48 hours of index visit (Emergency department arrival to emergency department or hospital discharge)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number/proportion of subjects experiencing resolution of symptoms with standard medical therapies
Time Frame: Within 48 hours of index visit (Emergency department arrival to emergency department or hospital discharge)
|
Number/proportion of subjects experiencing resolution of symptoms with standard medical therapies, including glucagon and carbonated beverages
|
Within 48 hours of index visit (Emergency department arrival to emergency department or hospital discharge)
|
|
Number/proportion of subjects requiring endoscopic intervention
Time Frame: Within 48 hours of index visit (Emergency department arrival to emergency department or hospital discharge)
|
Number/proportion of subjects needing interventional procedures during esophagogastroduodenoscopy due to esophageal symptoms
|
Within 48 hours of index visit (Emergency department arrival to emergency department or hospital discharge)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2207289
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Esophageal Obstruction
-
HealthPartners InstituteCompleted
-
Société Française d'Endoscopie DigestiveCompletedEsophageal Obstruction | Esophageal DisruptionFrance
-
Baylor Research InstituteEnrolling by invitationEsophagogastric Junction Outflow Obstruction | Achalasia, Esophageal | Spastic Esophageal DisordersUnited States
-
Chinese University of Hong KongAcademy tertiary center, IECED, Guayaquil, EcuadorRecruitingAchalasia | EGJ Outflow ObstructionHong Kong, Ecuador
-
Northwestern UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingJackhammer Esophagus | Type III Achalasia | EGJ Outflow Obstruction With Spastic/Hypercontractile Features | Distal Esophageal SpasmUnited States
-
Shandong Cancer Hospital and InstituteCompleted
-
Baylor Research InstituteActive, not recruitingEsophagogastric Junction Outflow ObstructionUnited States
-
Northwestern UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingType I Achalasia | Type II Achalasia | EGJ Outflow Obstruction Without Spastic/Hypercontractile FeaturesUnited States
-
Baylor College of MedicineCompletedSwallowing Disorders | Achalasia | Outlet Obstruction, Gastric | Diffuse Esophageal SpasmUnited States
-
Kansas City Veteran Affairs Medical CenterCompletedGastrostomy | Head and Neck Neoplasm | Esophageal Stenosis and ObstructionUnited States
Clinical Trials on Point of care ultrasound
-
University Hospital, CaenTerminatedDeep Vein ThrombosisFrance
-
Temple UniversityCompleted
-
Medical University of ViennaWithdrawnTelemedicine | EchocardiographyAustria
-
Indiana UniversityRecruitingPoint of Care Ultrasound (POCUS)United States
-
Scripps HealthBurl Concepts, Inc.RecruitingPatent Foramen Ovale (PFO)United States
-
Chinese University of Hong KongHospital Authority, Hong KongNot yet recruitingAortic Dissection | Thoracic Aortic Aneurysm (TAA)Hong Kong
-
Indiana UniversityRecruitingSickle Cell Disease | Acute Chest SyndromeUnited States
-
University College, LondonCompleted
-
Second Affiliated Hospital, School of Medicine,...CompletedCOVID-19 | Weaning | Lung Ultrasound | Diaphragm UltrasoundChina